CLINICAL COMPARISON OF 5% FLUORO CALCIUM PHOSPHOSILICATE VERSUS 5% CALCIUM SODIUM PHOSPHOSILICATE IN THE TREATMENT OF DENTINAL HYPERSENSITIVITY

Authors

  • Dr. Huda Hussain Postgraduate Scholar, Department of Periodontology, Government Dental College and Hospital, Srinagar, J&K. 190010.
  • Prof. Suhail Majid Jan HOD, Department of Periodontology, Government Dental College and Hospital, Srinagar, J&K. 190010.
  • Dr. Roobal Behal Assistant Professor, Department of Periodontology, Government Dental College and Hospital, Srinagar, J&K. 190010.

DOI:

https://doi.org/10.32553/ijmbs.v3i5.254

Abstract

Dentinal hypersensitivity is a perplexing problem for the patient as well as clinician. Among the plethora of pharmacological agents developed for the management of this rather common affliction, tubule occluding agents form the mainstay of treatment. Bioglasses (phosphosilicates) with evolving chemical and biological properties, are widely used, with the latest modification being the addition of fluoride to conventional calcium sodium phosphosilicate (Novamin) to result in fluoro calcium phosphosilicate (Biomin), purported to have superior tubule occlusive properties. The present study was designed as randomized clinical trial to compare the efficacy of Biomin and Novamin in reducing the subjective and provoked (thermal) experience of dentinal hypersensitivity. Sixty subjects were randomly prescribed three dentifrices after oral prophylaxis: Group A (20 patients):  dentifrice containing 5% fluoro calcium phosphosilicate (Biomin); Group B (20 patients): dentifrice containing 5% calcium sodium phosphosilicate (Novamin); Group C (20 patients): standard dentifrice containing fluoride. Subjective and thermal sensitivity was assessed using a 10 point VAS score at baseline, at 15 days, 30 days and 60 days of treatment. It was found that though significant reduction in hypersensitivity was observed for all three groups over time, flouro calcium phosphosilicate was most effective in reducing the VAS score, followed by calcium sodium phosphosilicate and fluoride. It was concluded that fluoro calcium phosphosilicate is a promising agent for clinical management of dentinal hypersensitivity.

Downloads

Published

2019-05-23

How to Cite

Hussain, D. H., Jan, P. S. M., & Behal, D. R. (2019). CLINICAL COMPARISON OF 5% FLUORO CALCIUM PHOSPHOSILICATE VERSUS 5% CALCIUM SODIUM PHOSPHOSILICATE IN THE TREATMENT OF DENTINAL HYPERSENSITIVITY. International Journal of Medical and Biomedical Studies, 3(5), 146-150. https://doi.org/10.32553/ijmbs.v3i5.254

Issue

Section

Research Articles